What Is Novaestiq & Saypha?
Did you know that Novaestiq was founded by former leaders from Galderma?
Humberto Antunes, the former global CEO of Galderma, and Miles Harrison, the former North American President of Galderma, co-founded Novaestiq in 2021 and now Novaestiq is with bringing Croma‑Pharma’s Saypha fillers to the U.S.
Saypha® is an established HA filler line built on Croma‑Pharma’s legacy—formerly marketed as “Princess”—and already used in over 80 countries, made with a proprietary 3D HA gel designed for predictable and natural results.
How Long Has Saypha Been Around & Where Is It Used?
Though the name Saypha is just a few years old, its foundation spans 40+ years of filler innovation at Croma. It’s currently used globally—especially in Europe—for lip enhancement and midface volume.
When U.S. Medical Spa’s Have Access To Saypha?
Obagi plans to launch Saypha ChIQ™ and MagIQ™ in the U.S. following FDA approval.
Saypha MagIQ’s PMA (pre-market approval that usually takes about 180 days) was submitted in August 2024, and Obagi is targeting late 2025 to early 2026 for a rollout, pending clearance.
What’s the Difference Between ChIQ™ & MagIQ™?
Right now, there are no in depth details and official specs are limited—but here’s what we can deduce:
-
ChIQ™: Likely optimized for midface contouring, including cheeks and subtle lift.
-
MagIQ™: Probably designed for deeper volume or structural facial work.
Both use the same high-quality HA base; the difference lies in gel density and performance characteristics. More details will arrive once Obagi releases provider materials.
Quick FAQ Table
| Question | Answer |
|---|---|
| Who’s behind this? | Waldencast acquired Novaestiq to bring Saypha fillers into the Obagi Medical brand. |
| What is Saypha? | A globally used HA filler from Croma‑Pharma, known for consistent, natural results. GlobeNewswireGlobal Cosmetic Industry |
| How long has it been used? | Since 2019 (rebranded), built on over 40 years of filler tech. PR NewswireGlobal Cosmetic Industry |
| Where is it used now? | In more than 80 countries for lip and midface work. GlobeNewswireNewBeauty |
| When in U.S.? | Likely in late 2025 to early 2026, once FDA approves. |
| Are the two fillers different? | Yes—ChIQ™ for contour, MagIQ™ for volume—both built on top-tier HA tech. |
Why This Matters for Medspa Owners & Providers
-
Brand familiarity meets injectables: Obagi, best known for skincare, is now adding fillers—an opportunity for clinics already offering Obagi to level up.
-
Streamlined cross-sell potential: Skincare clients become injectable candidates—boosting retention, spend, and overall satisfaction.
-
Science-first credibility: Saypha’s global data and production legacy offer reassurance to both providers and patients.
